Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Movano Inc.

Get SEC filing alerts via email and in your feed for Movano Inc.

MOVE

Movano Inc.

About Movano Inc.

Movano Inc. develops wearable health devices focused on women’s wellness and chronic disease management. Its products, including the Evie Ring and EvieMED Ring, provide medical-grade data on vital signs, blood oxygen, and menstrual health. The company aims to deliver non-invasive, continuous monitoring solutions for conditions like diabetes and hypertension, combining proprietary RF technology with consumer-friendly design to enhance preventative care and clinical applications.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from Movano Inc.

1
1
Movano Inc. Corvex Reports $510K Revenue Growth and $5M Net Loss Following Merger

Via official filing (AI summary) | 2 months ago | 0 comments

2
1
Movano Inc. Corvex Inc. Reports Fiscal Year 2025 Results with Revenue Decline and Merger Completion

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Movano Inc. Movano Inc. Reports Revenue Decline and Increased Losses in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
Movano Inc. Movano Inc. Reports Q2 2025 Revenue of $103,000, Sees Improvement in Losses

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Movano Inc. Movano Inc. Reports 76% Revenue Decline and $5.2 Million Net Loss in Q1 2025

Via official filing (AI summary) | 10 months ago | 0 comments

6
1
Movano Inc. Movano Inc. Reports $1M Revenue and FDA Clearance for EvieMED Ring in Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Movano Inc. Movano Inc. Reports Revenue Growth, Reduced Expenses, and Improved Financial Position in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments